key: cord-0686465-hy0hu9ee
authors: Ahouidi, Ambroise D.; Anderson, Mark; Diédhiou, Cyrille K.; Dia, Aminata; Mbow, Moustapha; Dia, Yacine; Mboup, Aminata; Gaye, Astou Gueye; Manga, Noel M.; Cloherty, Gavin; Mboup, Souleymane
title: Seroprevalence of SARS-CoV-2 IgG Antibodies in a Healthcare setting During the First Wave in Senegal
date: 2021-12-24
journal: IJID Regions
DOI: 10.1016/j.ijregi.2021.12.008
sha: 686f06eba74f5ebdb9a8f6b18daaa4f6dbdbdfff
doc_id: 686465
cord_uid: hy0hu9ee

This study describes the seroprevalence of SARS-CoV-2 IgG during the first wave in Senegal. The study aimed to identify the seroprevalence rate of SARS-CoV-2 IgG in 10 cities throughout Senegal by testing plasma from volunteers attending healthcare clinics for non-COVID-19 related reasons (n = 3231) collected between June and October of 2020. The overall positivity rate was 20.4% and large geographical differences in seropositivity (6-41.9%) were observed, suggesting that the true number of infections were substantially higher than the official estimates of 8.5%.

• Seroprevalence of SARS-CoV-2 IgG in 10 cities throughout Senegal by testing 3 plasma. 4 • Differences in seropositivity were observed between cities.

• COVID-19 in Senegal was higher than reported cases during the first wave. The first wave of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and Health estimated the prevalence of SARS-CoV-2 to be 8.5% based on PCR testing of 33 symptomatic patients, close contacts, and international travelers to estimate the total country 34 wide prevalence (Ministere de la Sante et de l'action Sociale, 2021).

In this short communication we report SARS-CoV-2 seroprevalence data from 3231 36 individuals across 10 regions in Senegal collected between June and October 2020. We 37 identified an adjusted SARS-CoV-2 IgG prevalence of 20.4%. This striking difference could 38 be explained by the lack of testing capacity, asymptomatic or mild infections, and willingness 39 to be tested due to social stigma associated with the disease. Additionally, we observed that (Table 1) . This setting was chosen due to availability of participants during early 47 lockdown of the first wave. Demographic data, including age, sex, and residential region of This investigation provides insights into the first wave of the COVID-19 epidemic in Senegal 77 which has reported very few positive cases (n=70125) relying on PCR based testing compared to an expected 3.4 million infections based on our seroprevalence study and estimates of the 79 2020 population. Similarly, the 20.4% positivity we obtained is much higher than the 8.5% 

POPULATION DU SÉNÉGAL 112 ANNÉE 2020

Ministere de la Sante et de l'action Sociale. COVID-19 au Sénégal Faits & Chiffres. Ministere 116 de la Sante et de l'action Social

GG Covid-19 working group. Intense and Mild Wave of COVID-19 120 in The Gambia: a Cohort Analysis

Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients

World Health Organization. WHO Coronavirus (COVID-19) Dashboard

106 ☒ The authors declare that they have no known competing financial interests or personal 107 relationships that could have appeared to influence the work reported in this paper. 108 109